Haleon (HLN) Enterprise Value (2021 - 2025)
Haleon (HLN) posted Enterprise Value of -$1.9 billion for Q4 2025, up 37.43% on a QoQ basis from -$3.0 billion in Q4 2024, and up 37.43% year-over-year from -$1.4 billion in Q4 2024.
Haleon (HLN) Enterprise Value (2021 - 2025) Analysis & Trends
Haleon's Enterprise Value history runs 5 years deep, the most recent figure standing at -$1.9 billion for Q4 2025.
- Quarterly Enterprise Value rose 37.43% year-over-year to -$1.9 billion in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$1.9 billion (up 37.43% YoY) and the FY2025 annual result came in at -$1.8 billion, up 37.72% from the prior year.
- Enterprise Value was -$1.9 billion for Q4 2025 at Haleon, up from -$3.0 billion in the prior quarter.
- Across five years, Enterprise Value topped out at -$235.3 million in Q2 2023 and bottomed at -$3.0 billion in Q4 2024.
- A 5-year average of -$1.2 billion and a median of -$942.4 million in 2022 frame the typical range for Enterprise Value.
- Annual changes were most pronounced in 2023 — Enterprise Value surged 86.42% — and 2024, when it sank 154.37%.
- Haleon's Enterprise Value stood at -$396.3 million in 2021, then plunged by 79.94% to -$713.1 million in 2022, then plunged by 64.29% to -$1.2 billion in 2023, then sank by 154.37% to -$3.0 billion in 2024, then soared by 37.43% to -$1.9 billion in 2025.
- Business Quant data shows HLN's Enterprise Value at -$1.9 billion in Q4 2025, -$3.0 billion in Q4 2024, and -$406.4 million in Q2 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 88.07 Bn | 86.20 Bn | - | -1.86 Bn |
| 2 | Teva Pharmaceutical Industries | 35.75 Bn | 32.01 Bn | 1.97 Bn | -3.74 Bn |
| 3 | Zoetis | 31.84 Bn | 29.90 Bn | 1.62 Bn | -1.94 Bn |
| 4 | Takeda Pharmaceutical | 27.18 Bn | 23.12 Bn | 4.39 Bn | -4.05 Bn |
| 5 | United Therapeutics | 23.09 Bn | 20.93 Bn | 648.10 Mn | -2.15 Bn |
| 6 | RedHill Biopharma | 21.32 Bn | 21.32 Bn | - | -3.97 Mn |
| 7 | Viatris | 19.96 Bn | 18.16 Bn | 1.16 Bn | -1.80 Bn |
| 8 | Neurocrine Biosciences | 17.66 Bn | 16.34 Bn | 800.70 Mn | -1.32 Bn |
| 9 | Elanco Animal Health | 12.44 Bn | 12.02 Bn | 785.00 Mn | -428.00 Mn |
| 10 | Vireo Growth | 10.53 Bn | 10.38 Bn | 59.30 Mn | -153.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -1.86 Bn |
| Dec 31, 2024 | -2.98 Bn |
| Jun 30, 2024 | -406.44 Mn |
| Dec 31, 2023 | -1.17 Bn |
| Jun 30, 2023 | -235.26 Mn |
| Dec 31, 2022 | -713.14 Mn |
| Jun 30, 2022 | -1.73 Bn |
| Dec 31, 2021 | -396.32 Mn |